Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The global Asthma & COPD market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Asthma & COPD volume and value at global level, regional level and company level. From a global perspective, this report represents overall Asthma & COPD market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Asthma & COPD in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Asthma & COPD manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Table of Contents
Executive Summary
1 Industry Overview of Asthma & COPD
1.1 Definition of Asthma & COPD
1.2 Asthma & COPD Segment by Type
1.2.1 Global Asthma & COPD Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Anti-inflammatory Drugs
1.2.3 Bronchodilator Monotherapy
1.2.4 Combination Drugs
1.3 Asthma & COPD Segment by Applications
1.3.1 Global Asthma & COPD Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Asthma & COPD Overall Market
1.4.1 Global Asthma & COPD Revenue (2014-2025)
1.4.2 Global Asthma & COPD Production (2014-2025)
1.4.3 North America Asthma & COPD Status and Prospect (2014-2025)
1.4.4 Europe Asthma & COPD Status and Prospect (2014-2025)
1.4.5 China Asthma & COPD Status and Prospect (2014-2025)
1.4.6 Japan Asthma & COPD Status and Prospect (2014-2025)
1.4.7 Southeast Asia Asthma & COPD Status and Prospect (2014-2025)
1.4.8 India Asthma & COPD Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Asthma & COPD
2.3 Manufacturing Process Analysis of Asthma & COPD
2.4 Industry Chain Structure of Asthma & COPD
3 Development and Manufacturing Plants Analysis of Asthma & COPD
3.1 Capacity and Commercial Production Date
3.2 Global Asthma & COPD Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Asthma & COPD
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Asthma & COPD Production and Capacity Analysis
4.2 Asthma & COPD Revenue Analysis
4.3 Asthma & COPD Price Analysis
4.4 Market Concentration Degree
5 Asthma & COPD Regional Market Analysis
5.1 Asthma & COPD Production by Regions
5.1.1 Global Asthma & COPD Production by Regions
5.1.2 Global Asthma & COPD Revenue by Regions
5.2 Asthma & COPD Consumption by Regions
5.3 North America Asthma & COPD Market Analysis
5.3.1 North America Asthma & COPD Production
5.3.2 North America Asthma & COPD Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Asthma & COPD Import and Export
5.4 Europe Asthma & COPD Market Analysis
5.4.1 Europe Asthma & COPD Production
5.4.2 Europe Asthma & COPD Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Asthma & COPD Import and Export
5.5 China Asthma & COPD Market Analysis
5.5.1 China Asthma & COPD Production
5.5.2 China Asthma & COPD Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Asthma & COPD Import and Export
5.6 Japan Asthma & COPD Market Analysis
5.6.1 Japan Asthma & COPD Production
5.6.2 Japan Asthma & COPD Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Asthma & COPD Import and Export
5.7 Southeast Asia Asthma & COPD Market Analysis
5.7.1 Southeast Asia Asthma & COPD Production
5.7.2 Southeast Asia Asthma & COPD Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Asthma & COPD Import and Export
Summary: Get latest Market Research Reports on Asthma & COPD. Industry analysis & Market Report on Asthma & COPD is a syndicated market report, published as Global Asthma & COPD Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Asthma & COPD market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.